Glen Eagle Advisors’s DexCom DXCM Stock Holding History

Glen Eagle Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.4K	Hold	288	–	–	﹤0.01%	597
2026 Q1	$18.1K	Hold	288	–	–	﹤0.01%	583
2025 Q4	$19.1K	Buy	288 +28	+11%	+$1.81K	﹤0.01%	592
2025 Q3	$17.5K	Hold	260	–	–	﹤0.01%	600
2025 Q2	$22.7K	Hold	260	–	–	﹤0.01%	534
2025 Q1	$17.8K	Hold	260	–	–	﹤0.01%	559
2024 Q4	$20.2K	Sell	260 -114	-30%	-$8.44K	﹤0.01%	548
2024 Q3	$25.1K	Hold	374	–	–	﹤0.01%	531
2024 Q2	$42.4K	Buy	374 +114	+44%	+$14.4K	0.01%	430
2024 Q1	$36.1K	Hold	260	–	–	0.01%	458
2023 Q4	$32.3K	Hold	260	–	–	0.01%	456
2023 Q3	$24.3K	Hold	260	–	–	0.01%	493
2023 Q2	$33.4K	Hold	260	–	–	0.01%	437
2023 Q1	$30.2K	Hold	260	–	–	0.01%	442
2022 Q4	$29.4K	Hold	260	–	–	0.01%	433
2022 Q3	$20.9K	Hold	260	–	–	0.01%	478
2022 Q2	$19.4K	Hold	260	–	–	0.01%	505
2022 Q1	$33.3K	Hold	260	–	–	0.01%	436
2021 Q4	$34.9K	Hold	260	–	–	0.01%	428
2021 Q3	$35.5K	Sell	260 -200	-43%	-$25.2K	0.01%	436
2021 Q2	$49.1K	Hold	460	–	–	0.02%	375
2021 Q1	$41.3K	Sell	460 -120	-21%	-$11.3K	0.01%	381
2020 Q4	$53.6K	Buy	580 +120	+26%	+$10.7K	0.02%	317
2020 Q3	$47.4K	Hold	460	–	–	0.02%	313
2020 Q2	$46.6K	Buy	+460	New	+$41.1K	0.02%	296

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Glen Eagle Advisors's DXCM Position: Q2 2026 in Review

Glen Eagle Advisors held its DexCom (DXCM) position steady in Q2 2026 at 288 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Glen Eagle Advisors first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $53.6K in Q4 2020. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Glen Eagle Advisors held 288 shares of DexCom worth $19.4K as of Q2 2026.
Glen Eagle Advisors left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #597 holding.
Glen Eagle Advisors first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
Glen Eagle Advisors's DexCom position peaked at $53.6K in Q4 2020.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.